• (Ref.) Doxazosin/terazosin is identified in the Beers
Criteria as a potentially inappropriate medication for
hypertension in patients 65 years and older due to its high
risk of orthostatic hypotension. Avoid use for hypertension
treatment (alternative agents have superior risk-benefit
profiles) (Beers Criteria [AGS 2019]).